BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 15367599)

  • 1. Synthesis and characterization of a native, oligomeric form of recombinant severe acute respiratory syndrome coronavirus spike glycoprotein.
    Song HC; Seo MY; Stadler K; Yoo BJ; Choo QL; Coates SR; Uematsu Y; Harada T; Greer CE; Polo JM; Pileri P; Eickmann M; Rappuoli R; Abrignani S; Houghton M; Han JH
    J Virol; 2004 Oct; 78(19):10328-35. PubMed ID: 15367599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenicity and receptor-binding ability of recombinant SARS coronavirus spike protein.
    Ho TY; Wu SL; Cheng SE; Wei YC; Huang SP; Hsiang CY
    Biochem Biophys Res Commun; 2004 Jan; 313(4):938-47. PubMed ID: 14706633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression, glycosylation, and modification of the spike (S) glycoprotein of SARS CoV.
    Shen S; Tan TH; Tan YJ
    Methods Mol Biol; 2007; 379():127-35. PubMed ID: 17502675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region.
    Chen Z; Zhang L; Qin C; Ba L; Yi CE; Zhang F; Wei Q; He T; Yu W; Yu J; Gao H; Tu X; Gettie A; Farzan M; Yuen KY; Ho DD
    J Virol; 2005 Mar; 79(5):2678-88. PubMed ID: 15708987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single tyrosine in the severe acute respiratory syndrome coronavirus membrane protein cytoplasmic tail is important for efficient interaction with spike protein.
    McBride CE; Machamer CE
    J Virol; 2010 Feb; 84(4):1891-901. PubMed ID: 20007283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential maturation and subcellular localization of severe acute respiratory syndrome coronavirus surface proteins S, M and E.
    Nal B; Chan C; Kien F; Siu L; Tse J; Chu K; Kam J; Staropoli I; Crescenzo-Chaigne B; Escriou N; van der Werf S; Yuen KY; Altmeyer R
    J Gen Virol; 2005 May; 86(Pt 5):1423-1434. PubMed ID: 15831954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies.
    He Y; Lu H; Siddiqui P; Zhou Y; Jiang S
    J Immunol; 2005 Apr; 174(8):4908-15. PubMed ID: 15814718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and protection efficacy of monomeric and trimeric recombinant SARS coronavirus spike protein subunit vaccine candidates.
    Li J; Ulitzky L; Silberstein E; Taylor DR; Viscidi R
    Viral Immunol; 2013 Apr; 26(2):126-32. PubMed ID: 23573979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single amino acid substitutions in the severe acute respiratory syndrome coronavirus spike glycoprotein determine viral entry and immunogenicity of a major neutralizing domain.
    Yi CE; Ba L; Zhang L; Ho DD; Chen Z
    J Virol; 2005 Sep; 79(18):11638-46. PubMed ID: 16140741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic analysis of the SARS-coronavirus spike glycoprotein functional domains involved in cell-surface expression and cell-to-cell fusion.
    Petit CM; Melancon JM; Chouljenko VN; Colgrove R; Farzan M; Knipe DM; Kousoulas KG
    Virology; 2005 Oct; 341(2):215-30. PubMed ID: 16099010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor.
    Babcock GJ; Esshaki DJ; Thomas WD; Ambrosino DM
    J Virol; 2004 May; 78(9):4552-60. PubMed ID: 15078936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying epitopes responsible for neutralizing antibody and DC-SIGN binding on the spike glycoprotein of the severe acute respiratory syndrome coronavirus.
    Shih YP; Chen CY; Liu SJ; Chen KH; Lee YM; Chao YC; Chen YM
    J Virol; 2006 Nov; 80(21):10315-24. PubMed ID: 17041212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Template-based coiled-coil antigens elicit neutralizing antibodies to the SARS-coronavirus.
    Tripet B; Kao DJ; Jeffers SA; Holmes KV; Hodges RS
    J Struct Biol; 2006 Aug; 155(2):176-94. PubMed ID: 16697221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cytoplasmic tail of the severe acute respiratory syndrome coronavirus spike protein contains a novel endoplasmic reticulum retrieval signal that binds COPI and promotes interaction with membrane protein.
    McBride CE; Li J; Machamer CE
    J Virol; 2007 Mar; 81(5):2418-28. PubMed ID: 17166901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Important role for the transmembrane domain of severe acute respiratory syndrome coronavirus spike protein during entry.
    Broer R; Boson B; Spaan W; Cosset FL; Corver J
    J Virol; 2006 Feb; 80(3):1302-10. PubMed ID: 16415007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV spike proteins expressed by the vaccinia virus Tiantan strain: secreted sq protein induces robust neutralization antibody in mice.
    Yan K; Tan W; Wang H; Wang Y; Zhang X; Li Y; Ruan L
    Viral Immunol; 2009 Feb; 22(1):57-66. PubMed ID: 19210229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV.
    Liu YV; Massare MJ; Barnard DL; Kort T; Nathan M; Wang L; Smith G
    Vaccine; 2011 Sep; 29(38):6606-13. PubMed ID: 21762752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice.
    Bisht H; Roberts A; Vogel L; Bukreyev A; Collins PL; Murphy BR; Subbarao K; Moss B
    Proc Natl Acad Sci U S A; 2004 Apr; 101(17):6641-6. PubMed ID: 15096611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative comparison of the efficiency of antibodies against S1 and S2 subunit of SARS coronavirus spike protein in virus neutralization and blocking of receptor binding: implications for the functional roles of S2 subunit.
    Zeng F; Hon CC; Yip CW; Law KM; Yeung YS; Chan KH; Malik Peiris JS; Leung FC
    FEBS Lett; 2006 Oct; 580(24):5612-20. PubMed ID: 16989815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenoviral expression of a truncated S1 subunit of SARS-CoV spike protein results in specific humoral immune responses against SARS-CoV in rats.
    Liu RY; Wu LZ; Huang BJ; Huang JL; Zhang YL; Ke ML; Wang JM; Tan WP; Zhang RH; Chen HK; Zeng YX; Huang W
    Virus Res; 2005 Sep; 112(1-2):24-31. PubMed ID: 16022898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.